No association between proton pump inhibitor use and ALS risk: a nationwide nested case–control study

Abstract The use of proton pump inhibitors (PPIs) has been proposed as a potential risk factor for neurodegenerative diseases, but little is known regarding its role in amyotrophic lateral sclerosis (ALS). We therefore aimed to assess the association of PPI use with the subsequent risk of ALS, and p...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hakan Cetin, Jiangwei Sun, Catarina Almqvist, Berthold Reichardt, Matthias Tomschik, Fritz Zimprich, Fang Fang, Caroline Ingre
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
R
Q
Acceso en línea:https://doaj.org/article/f9bb24ad6dd747789e8a5deeea35072a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!